APA (7th ed.) Citation

CL, B., JR, N., PR, Y., CC, T., DA, D., JM, M., . . . DM, C. (2007). Evaluation of serious adverse drug reactions: A proactive pharmacovigilance program (RADAR) vs safety activities conducted by the food and drug administration and pharmaceutical manufacturers. Archives of Internal Medicine, 167(10), 1041. https://doi.org/10.1001/archinte.167.10.1041

Chicago Style (17th ed.) Citation

CL, Bennett, et al. "Evaluation of Serious Adverse Drug Reactions: A Proactive Pharmacovigilance Program (RADAR) Vs Safety Activities Conducted by the Food and Drug Administration and Pharmaceutical Manufacturers." Archives of Internal Medicine 167, no. 10 (2007): 1041. https://doi.org/10.1001/archinte.167.10.1041.

MLA (9th ed.) Citation

CL, Bennett, et al. "Evaluation of Serious Adverse Drug Reactions: A Proactive Pharmacovigilance Program (RADAR) Vs Safety Activities Conducted by the Food and Drug Administration and Pharmaceutical Manufacturers." Archives of Internal Medicine, vol. 167, no. 10, 2007, p. 1041, https://doi.org/10.1001/archinte.167.10.1041.